Clarity Capital Partners LLC Sells 145 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Clarity Capital Partners LLC lowered its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.5% in the 4th quarter, Holdings Channel reports. The institutional investor owned 5,772 shares of the medical equipment provider’s stock after selling 145 shares during the period. Intuitive Surgical comprises approximately 1.6% of Clarity Capital Partners LLC’s investment portfolio, making the stock its 16th largest position. Clarity Capital Partners LLC’s holdings in Intuitive Surgical were worth $3,013,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently made changes to their positions in the business. Massachusetts Financial Services Co. MA bought a new position in shares of Intuitive Surgical in the third quarter worth approximately $558,807,000. International Assets Investment Management LLC grew its stake in Intuitive Surgical by 49,383.6% in the third quarter. International Assets Investment Management LLC now owns 1,090,619 shares of the medical equipment provider’s stock worth $535,788,000 after purchasing an additional 1,088,415 shares during the period. FMR LLC boosted its stake in Intuitive Surgical by 8.3% during the third quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after acquiring an additional 838,793 shares in the last quarter. Wilmington Savings Fund Society FSB boosted its position in shares of Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Finally, Strategic Financial Concepts LLC grew its stake in shares of Intuitive Surgical by 50,740.8% in the fourth quarter. Strategic Financial Concepts LLC now owns 312,671 shares of the medical equipment provider’s stock worth $163,202,000 after acquiring an additional 312,056 shares during the last quarter. Institutional investors own 83.64% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Jamie Samath sold 94 shares of the firm’s stock in a transaction that occurred on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares of the company’s stock, valued at approximately $1,502,019.30. This trade represents a 3.45 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Robert Desantis sold 376 shares of Intuitive Surgical stock in a transaction on Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the sale, the executive vice president now directly owns 5,506 shares of the company’s stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 6,348 shares of company stock valued at $3,587,582 over the last 90 days. Insiders own 0.90% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. Robert W. Baird raised their price target on shares of Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a research report on Thursday, October 17th. Leerink Partners upped their price target on shares of Intuitive Surgical from $490.00 to $548.00 in a research report on Monday, January 27th. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research report on Tuesday, November 19th. Raymond James lifted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. Finally, The Goldman Sachs Group set a $604.00 price objective on Intuitive Surgical in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and sixteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and an average price target of $613.10.

Intuitive Surgical Stock Performance

NASDAQ:ISRG opened at $589.61 on Thursday. The firm has a market capitalization of $210.01 billion, a PE ratio of 91.98, a PEG ratio of 5.67 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $364.17 and a fifty-two week high of $616.00. The stock’s fifty day moving average is $556.91 and its 200 day moving average is $516.98.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.